<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2664-2891</journal-id>
<journal-title><![CDATA[Revista científica ciencias de la salud]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. cient. cienc. salud]]></abbrev-journal-title>
<issn>2664-2891</issn>
<publisher>
<publisher-name><![CDATA[Universidad del Pacífico]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2664-28912024000100023</article-id>
<article-id pub-id-type="doi">10.53732/rccsalud/2024.e6152</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Características clínicas y demográficas de pacientes con trombosis venosa profunda en un hospital de referencia de Paraguay durante la pandemia de COVID-19 (2020-2023)]]></article-title>
<article-title xml:lang="en"><![CDATA[Clinical and demographic characteristics of patients with deep vein thrombosis in a referral hospital in Paraguay during the COVID-19 pandemic (2020-2023)]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alfonso-Balbuena]]></surname>
<given-names><![CDATA[Tamara]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Serna-Cuellar]]></surname>
<given-names><![CDATA[Alder Isaías Leonor]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Itapuá Facultad de Medicina Programa de Residencia en Medicina Interna]]></institution>
<addr-line><![CDATA[Encarnación ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Católica Nuestra Señora de la Asunción Facultad de Medicina Programa de Residencia en Emergentología]]></institution>
<addr-line><![CDATA[Villarrica ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>6</volume>
<fpage>23</fpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2664-28912024000100023&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2664-28912024000100023&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2664-28912024000100023&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Introducción. La enfermedad tromboembólica venosa, que incluye la trombosis venosa profunda (TVP), es la tercera enfermedad cardiovascular más frecuente a nivel mundial, con importante morbimortalidad. Objetivo. Describir las características clínicas y demográficas de los pacientes con Trombosis Venosa Profunda (TVP) internados en un hospital de referencia de Paraguay durante la pandemia de COVID-19 (2020-2023). Materiales y métodos. Estudio observacional, descriptivo, retrospectivo y de corte transversal. Se incluyeron 80 pacientes mayores de 18 años con diagnóstico confirmado de TVP, seleccionados mediante muestreo no probabilístico de casos consecutivos. Se recolectaron datos demográficos, clínicos y de tratamiento de los expedientes clínicos. Resultados. La edad media fue de 52 ± 17 años, con predominio del sexo femenino (55%, IC 95%: 44-66%). La enfermedad por COVID-19 fue la patología subyacente más frecuente (29%, IC95%: 19-39%). Según la escala de Wells, el 62.5% (IC95%: 51-73%) presentó riesgo moderado de TVP. La asimetría de miembro (65%, IC95%: 54-75%) y el dolor en pantorrilla (61.25%, IC95%: 50-72%) fueron los síntomas más frecuentes. El 72.5% (IC95%: 62-82%) recibió heparina de bajo peso molecular durante la internación. Conclusión. La TVP en este centro afectó predominantemente a mujeres de mediana edad, con COVID-19 como factor de riesgo emergente. Estos hallazgos subrayan la necesidad de una vigilancia activa de TVP en pacientes con COVID-19 y sugieren la importancia de estrategias de prevención y tratamiento adaptadas al contexto pandémico en Paraguay.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Introduction. Venous thromboembolic disease, which includes deep vein thrombosis (DVT), is the third most common cardiovascular disease worldwide, with significant morbidity and mortality. Objective. To describe the clinical and demographic characteristics of patients with Deep Vein Thrombosis (DVT) admitted to a referral hospital in Paraguay during the COVID-19 pandemic (2020-2023). Materials and methods. Observational, descriptive, retrospective, cross-sectional study. 80 patients over 18 years of age with a confirmed diagnosis of DVT were included, selected by non-probabilistic sampling of consecutive cases. Demographic, clinical, and treatment data were collected from medical records. Results. The mean age was 52 ± 17 years, with a predominance of females (55%, 95% CI: 44-66%). COVID-19 disease was the most frequent underlying pathology (29%, 95% CI: 19-39%). According to the Wells scale, 62.5% (95% CI: 51-73%) presented moderate risk of DVT. Limb asymmetry (65%, 95% CI: 54-75%) and calf pain (61.25%, 95% CI: 50-72%) were the most frequent symptoms. 72.5% (95% CI: 62-82%) received low molecular weight heparin during hospitalization. Conclusion. DVT in this center predominantly affected middle-aged women, with COVID-19 as an emerging risk factor. These findings underline the need for active surveillance of DVT in patients with COVID-19 and suggest the importance of prevention and treatment strategies adapted to the pandemic context in Paraguay.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[trombosis venosa profunda]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[anticoagulantes]]></kwd>
<kwd lng="es"><![CDATA[heparina de bajo peso molecular]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo]]></kwd>
<kwd lng="en"><![CDATA[deep vein thrombosis]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[anticoagulants]]></kwd>
<kwd lng="en"><![CDATA[low molecular weight heparin]]></kwd>
<kwd lng="en"><![CDATA[risk factors.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandino]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abordaje de trombosis venosa profunda en miembros inferiores]]></article-title>
<source><![CDATA[Revista Medica Sinergia]]></source>
<year>2020</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>e360</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Fajardo]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Bolaño Vaillant]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dosouto Infante]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Flores Ramírez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Pascual Díaz]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ecografía Doppler en el diagnóstico de trombosis venosa profunda de miembros inferiores]]></article-title>
<source><![CDATA[Multimed]]></source>
<year>2020</year>
<volume>24</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1271-82</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñoz Rodríguez]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico de la trombosis venosa profunda]]></article-title>
<source><![CDATA[Revista Clínica Española]]></source>
<year>2020</year>
<volume>220</volume>
<page-range>41-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Gómez]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[García-Pérez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Colorado-Cruz]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[López-Burgos]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[López-Zamora]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[León-Pérez]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethiology, risk factors and Whole blood viscosity index in thromboembolic venous disease]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc.]]></source>
<year>2023</year>
<volume>61</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>140-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Áinle]]></surname>
<given-names><![CDATA[FN]]></given-names>
</name>
<name>
<surname><![CDATA[Kevane]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?]]></article-title>
<source><![CDATA[Blood Adv.]]></source>
<year>2020</year>
<volume>4</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>5595-606</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alonso-Beato]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lago-Rodríguez]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[López-Rubio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Tórtola]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García-Fernández-Bravo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Oblitas]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of thrombosis recurrence among patients with COVID-19 and surgery-associated venous thromboembolism]]></article-title>
<source><![CDATA[Rev Clin Esp (Barc).]]></source>
<year>2023</year>
<volume>223</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>255-61</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bustillo Santandreu M de]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez López]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Feíto Castex]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
<name>
<surname><![CDATA[García Seco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Montes de Oca García]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[González Bustillo]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Morbi-mortalidad de la enfermedad tromboembólica venosa en el Hospital Universitario &#8220;Arnaldo Milián Castro&#8221;]]></article-title>
<source><![CDATA[Revista Cubana de Angiología y Cirugía Vascular]]></source>
<year>2022</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marini]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Lewis]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Petrone]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zenilman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence and effects of deep vein thrombosis on the outcome of patients with coronavirus disease 2019 infection]]></article-title>
<source><![CDATA[J Vasc Surg Venous Lymphat Disord.]]></source>
<year>2022</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>803-10</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cosmi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Borgese]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Legnani]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sartori]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Palareti]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex Differences in Clinical Presentation of Lower Extremity Deep Vein Thrombosis]]></article-title>
<source><![CDATA[J Women&#8217;s Health]]></source>
<year>2024</year>
<volume>33</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>758-64</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Brahmandam]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Valcarce-Aspegren]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zhuo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Tonnessen]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex differences in long-term outcomes of patients with deep vein thrombosis]]></article-title>
<source><![CDATA[Vascular]]></source>
<year>2023</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>994-1002</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilcox]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Smilowitz]]></surname>
<given-names><![CDATA[NR]]></given-names>
</name>
<name>
<surname><![CDATA[Seda]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Xia]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Hochman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex Differences in Thrombosis and Mortality in Patients Hospitalized for COVID-19]]></article-title>
<source><![CDATA[The American Journal of Cardiology]]></source>
<year>2022</year>
<volume>170</volume>
<page-range>112-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saliba Júnior]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[AFDJ]]></given-names>
</name>
<name>
<surname><![CDATA[Matarazzo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[GT]]></given-names>
</name>
<name>
<surname><![CDATA[Sobreira]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trombose venosa profunda de membros inferiores em pacientes com covid-19]]></article-title>
<source><![CDATA[J vasc bras.]]></source>
<year>2023</year>
<volume>22</volume>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamashita]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yachi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Takeyama]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nishimoto]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Tsujino]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Nakamura]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID Study]]></article-title>
<source><![CDATA[J Atheroscler Thromb.]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Currey]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ellsworth]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Khatun]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Upregulation of inflammatory genes and pathways links obesity to severe COVID-19]]></article-title>
<source><![CDATA[Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease]]></source>
<year>2024</year>
<volume>1870</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>167322</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lobanova]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Skuridina]]></surname>
<given-names><![CDATA[DV]]></given-names>
</name>
<name>
<surname><![CDATA[Bairova]]></surname>
<given-names><![CDATA[VE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiological aspects of the effect of obesity on the course of viral diseases]]></article-title>
<source><![CDATA[Endocrinology]]></source>
<year>2024</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>46-51</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancuso]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity and Respiratory Infections Including COVID-19]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Dixon]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Forno]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Obesity and Lung Disease]]></source>
<year>2024</year>
<page-range>301-20</page-range><publisher-name><![CDATA[Cham: Springer International Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reddy]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Savlania]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Naik]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rastogi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gorsi]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deep venous thrombosis manifestation of common femoral vein leiomyoma]]></article-title>
<source><![CDATA[annals]]></source>
<year>2020</year>
<volume>102</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>e141-4</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baroncini]]></surname>
<given-names><![CDATA[LAV]]></given-names>
</name>
<name>
<surname><![CDATA[Franca]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[AntonioVidal]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Valle]]></surname>
<given-names><![CDATA[CED]]></given-names>
</name>
<name>
<surname><![CDATA[Stahlke]]></surname>
<given-names><![CDATA[PSDB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlation of clinical features with the risk of lower limb deep vein thrombosis assessed by duplex ultrasound]]></article-title>
<source><![CDATA[J vasc bras.]]></source>
<year>2013</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>118-22</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Link]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Late Complications of Deep Venous Thrombosis: Painful Swollen Extremities and Non Healing Ulcers]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Okuyan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Venous Thrombosis - Principles and Practice]]></source>
<year>2012</year>
<publisher-name><![CDATA[InTech]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gibson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Nicolini]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Up to Date Guidance for the Clinical Management of Chronic Venous Disease]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg.]]></source>
<year>2022</year>
<volume>63</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>179-80</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rognoni]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lugli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Maleti]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Tarricone]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical guidelines versus current clinical practice for the management of deep vein thrombosis]]></article-title>
<source><![CDATA[J Vasc Surg Venous Lymphatic Disord]]></source>
<year>2021</year>
<volume>9</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1334-44</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative Pharmacology of Direct Oral Anticoagulants and Vitamin K Antagonist]]></article-title>
<source><![CDATA[BEMS Reports]]></source>
<year>2022</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>16-23</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
